126 related articles for article (PubMed ID: 28632880)
1. The Urokinase Receptor-Derived Peptide UPARANT Recovers Dysfunctional Electroretinogram and Blood-Retinal Barrier Leakage in a Rat Model of Diabetes.
Cammalleri M; Locri F; Marsili S; Dal Monte M; Pisano C; Mancinelli A; Lista L; Rusciano D; De Rosa M; Pavone V; Bagnoli P
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3138-3148. PubMed ID: 28632880
[TBL] [Abstract][Full Text] [Related]
2. Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System.
Cammalleri M; Dal Monte M; Locri F; Marsili S; Lista L; De Rosa M; Pavone V; Rusciano D; Bagnoli P
J Diabetes Res; 2017; 2017():2904150. PubMed ID: 29464181
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy.
Dal Monte M; Rezzola S; Cammalleri M; Belleri M; Locri F; Morbidelli L; Corsini M; Paganini G; Semeraro F; Cancarini A; Rusciano D; Presta M; Bagnoli P
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2392-407. PubMed ID: 25766585
[TBL] [Abstract][Full Text] [Related]
4. The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization.
Cammalleri M; Dal Monte M; Locri F; Lista L; Aronsson M; Kvanta A; Rusciano D; De Rosa M; Pavone V; André H; Bagnoli P
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2600–2611. PubMed ID: 27168367
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy.
Dal Monte M; Cammalleri M; Pecci V; Carmosino M; Procino G; Pini A; De Rosa M; Pavone V; Svelto M; Bagnoli P
J Cell Mol Med; 2019 Feb; 23(2):1034-1049. PubMed ID: 30426662
[TBL] [Abstract][Full Text] [Related]
6. The emerging roles of clusterin on reduction of both blood retina barrier breakdown and neural retina damage in diabetic retinopathy.
Zhang C; Nie J; Feng L; Luo W; Yao J; Wang F; Wang H
Discov Med; 2016 Apr; 21(116):227-37. PubMed ID: 27232509
[TBL] [Abstract][Full Text] [Related]
7. Effects of intravitreal injection of KH902, a vascular endothelial growth factor receptor decoy, on the retinas of streptozotocin-induced diabetic rats.
Huang J; Li X; Li M; Li S; Xiao W; Chen X; Cai M; Wu Q; Luo D; Tang S; Luo Y
Diabetes Obes Metab; 2012 Jul; 14(7):644-53. PubMed ID: 22340191
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen-rich saline prevents early neurovascular dysfunction resulting from inhibition of oxidative stress in STZ-diabetic rats.
Feng Y; Wang R; Xu J; Sun J; Xu T; Gu Q; Wu X
Curr Eye Res; 2013 Mar; 38(3):396-404. PubMed ID: 23252792
[TBL] [Abstract][Full Text] [Related]
9. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
11. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
[TBL] [Abstract][Full Text] [Related]
12. Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy.
Xu H; Zhang L; Gu L; Lu L; Gao G; Li W; Xu G; Wang J; Gao F; Xu JY; Yao J; Wang F; Zhang J; Xu GT
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1519-30. PubMed ID: 24508793
[TBL] [Abstract][Full Text] [Related]
13. Intraocular Delivery of miR-146 Inhibits Diabetes-Induced Retinal Functional Defects in Diabetic Rat Model.
Zhuang P; Muraleedharan CK; Xu S
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1646-1655. PubMed ID: 28297724
[TBL] [Abstract][Full Text] [Related]
14. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
15. Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR).
Rao VR; Prescott E; Shelke NB; Trivedi R; Thomas P; Struble C; Gadek T; O'Neill CA; Kompella UB
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5198-204. PubMed ID: 20445119
[TBL] [Abstract][Full Text] [Related]
16. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
17. Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy.
Locri F; Pesce NA; Aronsson M; Cammalleri M; De Rosa M; Pavone V; Bagnoli P; Kvanta A; Dal Monte M; André H
J Mol Med (Berl); 2020 Nov; 98(11):1629-1638. PubMed ID: 32940719
[TBL] [Abstract][Full Text] [Related]
18. Early retinal damage in experimental diabetes: electroretinographical and morphological observations.
Li Q; Zemel E; Miller B; Perlman I
Exp Eye Res; 2002 May; 74(5):615-25. PubMed ID: 12076083
[TBL] [Abstract][Full Text] [Related]
19. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
[TBL] [Abstract][Full Text] [Related]
20. Normalization of retinal vascular permeability in experimental diabetes with genistein.
Nakajima M; Cooney MJ; Tu AH; Chang KY; Cao J; Ando A; An GJ; Melia M; de Juan E
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2110-4. PubMed ID: 11481279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]